Chrysovalantis Voutouri

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Coronavirus Disease

Inflammatory Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, Andreas G Hadjigeorgiou, Chloe Symeonidou, Eleni Porfyriou, Christina Michael, Andreas Stylianou, John D Martin, Horacio Cabral, Anastasia Constantinidou, Triantafyllos Stylianopoulos
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, Andreas G Hadjigeorgiou, Chloe Symeonidou, Eleni Porfyriou, Christina Michael, Andreas Stylianou, John D Martin, Horacio Cabral, Anastasia Constantinidou, Triantafyllos Stylianopoulos
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Lance L Munn, Rakesh K Jain, Triantafyllos Stylianopoulos
Dynamic heterogeneity in COVID-19: Insights from a mathematical model. PloS one 19 (5) (2024)
Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, Andreas G Hadjigeorgiou, Chloe Symeonidou, Eleni Porfyriou, Christina Michael, Andreas Stylianou, John D Martin, Horacio Cabral, Anastasia Constantinidou, Triantafyllos Stylianopoulos
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, Andreas G Hadjigeorgiou, Chloe Symeonidou, Eleni Porfyriou, Christina Michael, Andreas Stylianou, John D Martin, Horacio Cabral, Anastasia Constantinidou, Triantafyllos Stylianopoulos
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, Mohammad R Nikmaneshi, Melin J Khandekar, Justin F Gainor, Lance L Munn, Rakesh K Jain, Triantafyllos Stylianopoulos
Dynamic heterogeneity in COVID-19: Insights from a mathematical model. PloS one 19 (5) (2024)
Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri, Andreas G Hadjigeorgiou, Chloe Symeonidou, Eleni Porfyriou, Christina Michael, Andreas Stylianou, John D Martin, Horacio Cabral, Anastasia Constantinidou, Triantafyllos Stylianopoulos
Stabilizing tumor resident mast cells restores T cell infiltration and sensitizes sarcomas to PD-L1 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Antonia Charalambous, Fotios Mpekris, Myrofora Panagi, Chrysovalantis Voutouri, Christina Michael, Alberto A Gabizon, Triantafyllos Stylianopoulos
Tumor microenvironment reprogramming improves nanomedicine-based chemo-immunotherapy in sarcomas. Molecular cancer therapeutics (2024)